Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?

被引：10
|
作者：
Goldenberg, Ronald M. [1 ]
Verma, Subodh [2 ]
Perkins, Bruce A. [3 ]
Gilbert, Jeremy D. [4 ]
Zinman, Bernard [5 ]
机构：
[1] LMC Diabet & Endocrinol, Thornhill, ON, Canada
[2] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Surg,Div Cardiac Surg, Toronto, ON, Canada
[3] Univ Toronto, Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Endocrinol & Metab, Toronto, ON, Canada
[5] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
CANADIAN JOURNAL OF DIABETES | 2017年 / 41卷 / 01期
关键词：
TYPE-2; DIABETES-MELLITUS; PANCREATIC ALPHA-CELLS; DAPAGLIFLOZIN ADD-ON; DOUBLE-BLIND; POSTPRANDIAL GLUCAGON; BETA-CELLS; METFORMIN; THERAPY; SAXAGLIPTIN; SECRETION;
D O I：
10.1016/j.jcjd.2016.08.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 9
页数：4
相关论文
共 50 条
  • [41] Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world
    MacIsaac, Richard J.
    Ekinci, Elif I.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [42] Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lin, Kai-Jung
    Wang, Tzu-Jou
    Chen, Shang-Der
    Lin, Kai-Lieh
    Liou, Chia-Wei
    Lan, Min-Yu
    Chuang, Yao-Chung
    Chuang, Jiin-Haur
    Wang, Pei-Wen
    Lee, Jong-Jer
    Wang, Feng-Sheng
    Lin, Hung-Yu
    Lin, Tsu-Kung
    ANTIOXIDANTS, 2021, 10 (12)
  • [43] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review (vol 5, pg 161, 2016)
    Kalra, Sanjay
    Sahay, Rakesh
    Baruah, Manash P.
    CARDIOLOGY AND THERAPY, 2016, 5 (02) : 169 - 169
  • [44] Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
    Gamaza-Chulian, Sergio
    Diaz-Retamino, Enrique
    Gonzalez-Teston, Fatima
    Carlos Gaitero, Jose
    Jose Castillo, Maria
    Alfaro, Raquel
    Rodriguez, Elias
    Gonzalez-Caballero, Eva
    Martin-Santana, Antonio
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [45] A Pilot Study to Determine Outcomes in Lung Transplant Recipients Using Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
    Kukrety, S. P.
    Singh, A.
    Brink, H.
    Bailey, K. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [46] Nephrologist Use of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Relative to Other Specialties, 2015-2022
    Adhikari, Rishav
    Jha, Kunal
    Blaha, Michael J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 572 - 572
  • [47] Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
    Fatima, Aroob
    Rasool, Sohaib
    Devi, Sapna
    Talha, Muhammad
    Waqar, Fahad
    Nasir, Muhammad
    Khan, Mohammad R.
    Jaffari, Syed M. Ibne Ali
    Haider, Anum
    Shah, Syeda U.
    Sapna, Fnu
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    Mohamad, Tamam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [48] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases
    Pham, Linh Thi Truc
    Mangmool, Supachoke
    Parichatikanond, Warisara
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (11) : 3279 - 3298
  • [49] The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation
    Lescano, Caroline Honaiser
    Leonardi, Guilherme
    Portugal Torres, Pedro Henrique
    Amaral, Tiago Nardi
    de Freitas Filho, Luiz Henrique
    Antunes, Edson
    Vicente, Cristina Pontes
    Anhe, Gabriel Forato
    Monica, Fabiola Zakia
    BIOCHEMICAL PHARMACOLOGY, 2020, 182
  • [50] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors as a Dual Therapeutic Target for Cardiovascular and Renal Health: A Narrative Review
    Al Rashid, Sulthan
    Madar, Inamul Hasan
    Misbah, Iffath
    Dhanabalan, Kamalakannan
    Balasubramanian, Rajkapoor
    Maideen, Naina Mohamed Pakkir
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2025,
12345